Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model

Transplant Proc. 2001 Feb-Mar;33(1-2):223-4. doi: 10.1016/s0041-1345(00)01983-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • CD40 Ligand / immunology*
  • Dose-Response Relationship, Immunologic
  • Graft Rejection / prevention & control*
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / immunology*
  • Macaca mulatta
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • CD40 Ligand
  • Mycophenolic Acid